インスリン注入ポンプの世界市場：洞察、競合情勢、市場予測：2030年

世界のインスリン注入ポンプの市場規模は、2023年に64億8,000万米ドルとなりました。同市場は、2024年から2030年の予測期間中に8.69％のCAGRで拡大し、2030年には106億8,000万米ドルに達すると予測されています。 インスリン注入ポンプ市場は、糖尿病有病率の上昇、座りがちなライフスタイルの増加、糖尿病を発症しやすい高齢化人口の増加、インスリン注入ポンプの安全性と使いやすさの向上への注目の高まりなどの要因により繁栄することが予想されており、さらに予測期間中にはインスリン注入ポンプ市場でかなりの収益の成長をもたらすことが期待されています。

インスリン注入ポンプ市場の注目すべき促進要因としては、糖尿病有病率の上昇、糖尿病に対する意識の高まり、生活習慣の悪化などが挙げられます。

国際糖尿病連合（International Diabetes Federation 2022）が発表したデータによると、世界全体で20～79歳の成人の約5億3,700万人が糖尿病を患っており、この数は2030年までに6億4,300万人、2045年までに7億8,300万人に増加すると推定されています。糖尿病の場合、膵臓は十分なインスリンを生成することができないか、体が適切にインスリンを利用することができません。インスリン注入ポンプは、間隔をあけて短時間のインスリンを投与することで、人工膵臓のような働きをします。

さらに、糖尿病を発症しやすい高齢者人口が増加していることも、インスリン注入ポンプの成長の主な要因です。世界保健機関（WHO）の2022年のデータによると、2050年までに60歳以上の人口は21億人に達します。糖尿病は、高齢に伴う一般的な健康状態のひとつです。例えば、米国疾病予防管理センター（Centers for Disease Control and Prevention 2022）によると、米国では65歳以上の約2,640万人が糖尿病予備軍であり、糖尿病にかかるリスクが高いとみられています。

したがって、糖尿病の有病率の上昇は、インスリン注入ポンプの需要を促進し、最終的には予測期間中に世界のインスリン注入ポンプ市場の成長をリードすると予想されます。

当レポートでは、世界のインスリン注入ポンプ市場について調査し、市場の概要とともに、製品タイプ別、コンポーネント別、流通チャネル別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 インスリン注入ポンプ市場レポートのイントロダクション

第2章 インスリン注入ポンプ市場のエグゼクティブサマリー

第3章 規制分析

• 米国
• 欧州
• 日本
• 中国

第4章 インスリン注入ポンプ市場の主な要因分析

• インスリン注入ポンプ市場の促進要因
• インスリン注入ポンプ市場の抑制要因と課題
• インスリン注入ポンプ市場の機会

第5章 インスリン注入ポンプ市場におけるポーターのファイブフォース分析

第6章 インスリン注入ポンプ市場に対するCOVID-19の影響分析

第7章 インスリン注入ポンプの市場概要

• 製品タイプ別
• コンポーネント別
• 流通チャネル別
• 地域別

第8章 インスリン注入ポンプ市場の世界の企業シェア分析-主要3～5社

第9章 インスリン注入ポンプ市場の企業と製品プロファイル

• F. Hoffmann-La Roche Ltd
• Medtrum Technologies Inc
• A. Menarini Diagnostics S.R.L
• IA Collaborative Holdings, LLC
• Apex Medical
• Medtronic
• Insulet Corporation
• Ascensia Diabetes Care Holdings AG
• Ypsomed AG
• Tandem Diabetes Care, Inc.
• ICU Medical, Inc.
• SOOIL Developments Co., Ltd.
• MicroPort Scientific Corporation
• Microtec Medical

第10章 KOL の見解

第11章 プロジェクトのアプローチ

第12章 DelveInsightについて

第13章 免責事項とお問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: COVID-19 Impact Analysis on Contact Lenses Market
• Table 3: Insulin Infusion Pumps Market in Global (2021-2030)
• Table 4: Insulin Infusion Pumps Market in Global by Product Type (2021-2030)
• Table 5: Insulin Infusion Pumps Market in Global by Component (2021-2030)
• Table 6: Insulin Infusion Pumps Market in Global by Distribution Channel (2021-2030)
• Table 7: Insulin Infusion Pumps Market in Global by Geography (2021-2030)
• Table 8: Insulin Infusion Pumps Market in North America (2021-2030)
• Table 9: Insulin Infusion Pumps Market in North America by Country (2021-2030)
• Table 10: Insulin Infusion Pumps Market in the US (2021-2030)
• Table 11: Insulin Infusion Pumps Market in Canada (2021-2030)
• Table 12: Insulin Infusion Pumps Market in Mexico (2021-2030)
• Table 13: Insulin Infusion Pumps Market in Europe (2021-2030)
• Table 14: Insulin Infusion Pumps Market in Europe by Country (2021-2030)
• Table 15: Insulin Infusion Pumps Market in France (2021-2030)
• Table 16: Insulin Infusion Pumps Market in Germany (2021-2030)
• Table 17: Insulin Infusion Pumps Market in the United Kingdom (2021-2030)
• Table 18: Insulin Infusion Pumps Market in Italy (2021-2030)
• Table 19: Insulin Infusion Pumps Market in Spain (2021-2030)
• Table 20: Insulin Infusion Pumps Market in Russia (2021-2030)
• Table 21: Insulin Infusion Pumps Market in Rest of Europe (2021-2030)
• Table 22: Insulin Infusion Pumps Market in APAC (2021-2030)
• Table 23: Insulin Infusion Pumps Market in APAC by Country (2021-2030)
• Table 24: Insulin Infusion Pumps Market in China (2021-2030)
• Table 25: Insulin Infusion Pumps Market in Japan (2021-2030)
• Table 26: Insulin Infusion Pumps Market in India (2021-2030)
• Table 27: Insulin Infusion Pumps Market in Australia (2021-2030)
• Table 28: Insulin Infusion Pumps Market in South Korea (2021-2030)
• Table 29: Insulin Infusion Pumps Market in Rest of APAC (2021-2030)
• Table 30: Insulin Infusion Pumps Market in Rest of World (2021-2030)
• Table 31: Insulin Infusion Pumps Market in RoW by Region (2021-2030)
• Table 32: Insulin Infusion Pumps Market in Middle East (2021-2030)
• Table 33: Insulin Infusion Pumps Market in Africa (2021-2030)
• Table 34: Insulin Infusion Pumps Market in South America (2021-2030)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: COVID-19 Impact Analysis on Contact Lenses Market
• Figure 3: Insulin Infusion Pumps Market in Global (2021-2030)
• Figure 4: Insulin Infusion Pumps Market in Global by Product Type (2021-2030)
• Figure 5: Insulin Infusion Pumps Market in Global by Component (2021-2030)
• Figure 6: Insulin Infusion Pumps Market in Global by Distribution Channel (2021-2030)
• Figure 7: Insulin Infusion Pumps Market in Global by Geography (2021-2030)
• Figure 8: Insulin Infusion Pumps Market in North America (2021-2030)
• Figure 9: Insulin Infusion Pumps Market In North America by Country (2021-2030)
• Figure 10: Insulin Infusion Pumps Market in the US (2021-2030)
• Figure 11: Insulin Infusion Pumps Market in Canada (2021-2030)
• Figure 12: Insulin Infusion Pumps Market in Mexico (2021-2030)
• Figure 13: Insulin Infusion Pumps Market in Europe (2021-2030)
• Figure 14: Insulin Infusion Pumps Market in Europe by Country (2021-2030)
• Figure 15: Insulin Infusion Pumps Market in France (2021-2030)
• Figure 16: Insulin Infusion Pumps Market in Germany (2021-2030)
• Figure 17: Insulin Infusion Pumps Market in the United Kingdom (2021-2030)
• Figure 18: Insulin Infusion Pumps Market in Italy (2021-2030)
• Figure 19: Insulin Infusion Pumps Market in Spain (2021-2030)
• Figure 20: Insulin Infusion Pumps Market in Russia (2021-2030)
• Figure 21: Insulin Infusion Pumps Market in Rest of Europe (2021-2030)
• Figure 22: Insulin Infusion Pumps Market in APAC (2021-2030)
• Figure 23: Insulin Infusion Pumps Market in APAC by Country (2021-2030)
• Figure 24: Insulin Infusion Pumps Market in China (2021-2030)
• Figure 25: Insulin Infusion Pumps Market in Japan (2021-2030)
• Figure 26: Insulin Infusion Pumps Market in India (2021-2030)
• Figure 27: Insulin Infusion Pumps Market in Australia (2021-2030)
• Figure 28: Insulin Infusion Pumps Market in South Korea (2021-2030)
• Figure 29: Insulin Infusion Pumps Market in Rest of APAC (2021-2030)
• Figure 30: Insulin Infusion Pumps Market in Rest of World (2021-2030)
• Figure 31: Insulin Infusion Pumps Market in RoW by Region (2021-2030)
• Figure 32: Insulin Infusion Pumps Market in Middle East (2021-2030)
• Figure 33: Insulin Infusion Pumps Market in Africa (2021-2030)
• Figure 34: Insulin Infusion Pumps Market in South America (2021-2030)
• Figure 35: Market Drivers
• Figure 36: Market Barriers
• Figure 37: Marker Opportunities
• Figure 38: PORTER'S Five Force Analysis

Insulin Infusion Pumps Market By Product Type (Patch Pump, Tethered Pump And Others), By Component Type (Insulin Pump, Infusion Sets, Reservoir), By Distribution Channels (Hospitals And Retail Pharmacy, E-Commerce Sites, And Others) by geography is estimated to register growth at a remarkable CAGR forecast during 2024-2030 owing to a surge in the prevalence of diabetes and increasing sedentary lifestyle

The global insulin infusion pumps market was valued at USD 6.48 billion in 2023, growing at a CAGR of 8.69% during the forecast period from 2024 to 2030 to reach USD 10.68 billion by 2030. The insulin infusion pumps market is slated to witness prosperity owing to factors such as growing prevalence of diabetes, increasing sedentary lifestyle, growing aging population base which is susceptible to the development of diabetes, and the growing focus on improving the safety and usability of insulin infusion pumps are further expected to result in the appreciable revenue growth in the insulin infusion pumps market during the forecast period (2024-2030).

Insulin Infusion Pumps Market Dynamics:

Some of the noteworthy drivers of the insulin infusion pumps market is the rising prevalence of diabetes, increasing awareness on diabetes, and poor lifestyle, among others.

As per the data published by the International Diabetes Federation 2022, globally around 537 million adults aged between 20 and 79 years have diabetes and this number is estimated to rise to 643 million by 2030 and 783 million by 2045. In case of diabetes the pancreas are either not able to produce enough insulin or the body is not able to make use of insulin properly. Insulin infusion pumps works like artificial pancreas by delivering short doses of insulin at intervals.

Additionally, the growing geriatric population that is highly prone to the development of diabetes is another major factor for the growth of insulin infusion pumps. As per the data cited by the World Health Organization 2022, by 2050, the world population having number of people with age 60 years or above will reach up to 2.1 billion. Diabetes is among the common health conditions that are associated with the old age. For instance, according to the Centers for Disease Control and Prevention 2022, around 26.4 million people aged between 65 years and above have pre-diabetic condition in the US that is they are at high risk to suffer from diabetes.

Thus, the rising prevalence of diabetes is expected to drive the demand for insulin infusion pumps eventually leading the global insulin infusion pumps market growth during the forecast period (2024-2030).

The various advantages associated with the insulin infusion pumps is another key factor responsible for the growth of the insulin infusion pumps market. For instance, with insulin infusion pumps the case of multiple times needling is not there, also these pumps provide accurate dose of insulin every time and thus help in proper management of blood sugar levels. Moreover, managing insulin doses at the time of meal, snacks, exercise, and sleep is much easier and effective with insulin infusion pumps over other methods.

However, the availability of alternative products and high cost of insulin infusion pumps may act as restraining factors to the insulin infusion pumps market growth.

The insulin infusion pumps market reported a short period of restraint in the market growth during the initial stages of pandemic due to the implementation of lockdown as necessary measures to stop the spread of COVID-19 infection. This led to a halt in the manufacturing and supply of insulin infusion pumps, ultimately causing its shortage across the hospitals and retail pharmacy all over the world. Also, since diabetes patients were on a very high risk to get COVID, most of them were advised to avoid going outside from their homes, further leading to a decline in the market. However, later owing to some lockdown relaxations and for the sake of safety of diabetic patients who can't survive without insulin, the demand for the pumps increased and the insulin infusion pumps along with other necessary medications were started getting actively delivered at homes through e-commerce sites. Therefore, with the resumption of activities across industries including the healthcare sector, it has been uplifting for the insulin infusion pumps market during the forecast period from 2024-2030.

Insulin Infusion Pumps Market Segment Analysis:

Insulin Infusion Pumps Market By Product Type (Patch Pump, Tethered Pump and Others), Component Type (Insulin Pump, Infusion Sets, and Reservoir), Distribution Channels (Hospitals and Retail Pharmacy, E-Commerce Sites, and Others) Geography (North America, Europe, Asia-Pacific, and Rest of the World)

Based on the product type segment of the insulin infusion pumps market, the patch pump category is projected to register a significant growth in revenue in the insulin infusion pumps market during the forecast period (2024-2030). This can be ascribed to various advantages associated with the patch pump such as their small size, simple design, tubeless design, and others.

The availability of patch pumps in varying shapes, sizes, and technologies allow diabetes patients to choose as per their requirements.

The limitations associated with conventional insulin pumps comprise of the risk of clogging, visible infusion sets, skin changes, kinked tube, and others, in contrast to the patch pumps. Moreover, the risk of tangling, catching, or pulling of tube while doing some day-to-day activities such as playing sports, and others is also not present with the patch pumps.

Hence, the problems related with conventional insulin infusion pumps tends to shift patients to patch pump that are tubeless and offer multiple benefits including reduced risk of clogging, water resistant properties, allow to move freely, and others. Also, they are comparatively small and lightweight than conventional insulin infusion pumps.

The rate of insulin infusion can be remotely controlled in patch pumps. Patch pumps can be attached with various parts of body providing more discretion. In most of the patch pumps, the automatic needle insertion property is present making the application of patch pumps almost pain free. Patch pumps are also easy to handle with simple training and reducing treatment errors.

Therefore, considering the growing demand for this product type, numerous new products are being launched and approved in the market. In January 2022, Insulet received the US Food and Drug Administration clearance for Omnipod 5 system which is a tubeless automated insulin delivery (AID) system for Type 1 diabetes patients aged 6 and above. Also, in August 2022, the Omnipod 5 system was approved for children aged 2 years or above, suffering from Type 1 diabetes mellitus. Therefore, considering the advantages associated with patch pumps and their growing popularity among end users, this product category is expected to generate considerable revenue thereby pushing the overall growth of the global insulin infusion pumps market during the forecast period.

North America is expected to dominate the overall Insulin Infusion Pumps Market:

Among all the regions, North America is expected to lead in revenue generation in the global insulin infusion pumps market. This can be ascribed to the presence of large patient pool associated with diabetes which can further be attributed to an increase in the sedentary lifestyle, high consumer awareness regarding new market launches and a highly potent market in terms of product development and launches, and the local presence of key market players among other factors in the region.

One of the prominent factors supporting the growth of the North America insulin infusion pumps market is the rising prevalence of diabetes in the United States. For instance, as per the Centers for Disease Control and Prevention (CDC) 2022, around 28.7 million people in the US had diabetes in the year 2019. Moreover, as per the Centers for Disease Control and Prevention 2022 data, around 96 million people had prediabetic condition in the year 2019 in the US.

Further, the increasing poor lifestyle leading to obesity, and other health issues in the region is likely to boost the market for insulin infusion pumps. For example, according to Centers for Disease Control and Prevention (CDC) 2022, the obesity prevalence was 41.9% in 2017 - March 2020 in the US region. Obesity is one of the major risk factor for the development of type 2 diabetes and thus increasing the demand for insulin infusion pumps leading to its market growth.

Therefore, the presence of large insulin infusion pump user base coupled with the increasing focus of manufacturers on launching new products in the market is expected to bolster the growth of the insulin infusion pumps market in the United States during the forecast period.

Insulin Infusion Pumps Market Key Players:

Some of the key market players operating in the contact lenses market includes F. Hoffmann-La Roche Ltd, Medtronic, Medtrum Technologies Inc., A. Menarini Diagnostic's s.r.l., IA Collaborative Holdings, LLC, Apex Medical, Insulet Corporation, Ascensia Diabetes Care Holdings AG, Ypsomed AG, Tandem Diabetes Care, Inc., ICU Medical, Inc., SOOIL Developments Co., Ltd., MicroPort Scientific Corporation, Microtec Medical, and others.

Recent Developmental Activities in Insulin Infusion Pumps Market:

In September 2020, Medtronic had received the U.S. Food and Drug Administration (FDA) clearance for its MiniMed 770G system which is a new insulin pump system providing smartphone connectivity and an expanded age indication to ages 2 and above.

In October 2019, Novo Nordisk announced that the U.S. Food and Drug Administration (FDA) has expanded the label for Fiasp® (insulin aspart injection) to be included in insulin infusion pumps for the improvement of glycaemic control in adults with type 1 or type 2 diabetes.

In February 2019, Tandem Diabetes Care, received U.S. Food and Drug Administration (FDA) approval for its Slim X2 insulin pump that is used for delivering insulin under the skin for children and adults with diabetes.

Key Takeaways from the Insulin Infusion Pumps Market Report Study

• Market size analysis for current insulin infusion pumps market size (2023), and market forecast for 5 years (2024-2030).
• The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the insulin infusion pumps market.
• Top key product/services/technology developments, mergers, acquisitions, partnerships, joint ventures happened for last 3 years
• Key companies dominating the global insulin infusion pumps market.
• Various opportunities available for the other competitor in the insulin infusion pumps market space.
• What are the top performing segments in 2023? How these segments will perform in 2030.
• Which is the top-performing regions and countries in the current insulin infusion pumps market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for insulin infusion pumps market growth in the coming future?

Target Audience who can be benefited from this Insulin Infusion Pumps Market Report Study

• Insulin infusion pumps products providers
• Research organizations and consulting companies
• Insulin infusion pumps-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and Traders dealing in insulin infusion pumps
• Various end users who want to know more about the insulin infusion pumps market and latest technological developments in the insulin infusion pumps market.

Frequently Asked Questions for Contact Lenses Market:

1. What are insulin infusion pumps?

Insulin infusion pump is a small, portable medical device that is worn externally either in the patient's pocket or on a special belt and is intended for the administration of insulin for the treatment of diabetes mellitus.

2. What is the market for the global insulin infusion pumps?

The global insulin infusion pumps market was valued at USD 6.48 billion in 2023, growing at a CAGR of 8.69% during the forecast period from 2024 to 2030 to reach USD 10.68 billion by 2030.

3. What are the drivers for the global insulin infusion pumps market?

The insulin infusion pumps market is slated to witness prosperity owing to factors such as growing prevalence of diabetes, increasing sedentary lifestyle, growing aging population base which is susceptible to the development of diabetes, and the growing focus on improving the safety and usability of insulin infusion pumps are further expected to result in the appreciable revenue growth in the insulin infusion pumps market during the forecast period (2024-2030).

4. Who are the key players operating in the global insulin infusion pumps market?

Some of the key market players operating in the insulin infusion pumps market includes F. Hoffmann-La Roche Ltd, Medtronic, Medtrum Technologies Inc., A. Menarini Diagnostics s.r.l., IA Collaborative Holdings, LLC, Apex Medical, Insulet Corporation, Ascensia Diabetes Care Holdings AG, Ypsomed AG, Tandem Diabetes Care, Inc., ICU Medical, Inc., SOOIL Developments Co., Ltd., MicroPort Scientific Corporation, Microtec Medical, and others.

5. Which region has the highest share in the insulin infusion pumps market?

North America is expected to dominate the overall insulin infusion pumps market during the forecast period, 2024 to 2030. This can be ascribed to the presence of large patient pool associated with the diabetes which can further be attributed to the increase in poor lifestyle, high consumer awareness regarding new market launches and a highly potent market in terms of product development and launches, and the local presence of key market players among other factors in the region.

Table of Contents

1. Insulin Infusion Pumps Market Report Introduction

2. Insulin Infusion Pumps Market Executive Summary

• 2.1. Scope of the Study
• 2.2. Market at Glance
• 2.3. Competitive Assessment
• 2.4. Financial Benchmarking

3. Regulatory Analysis

• 3.1. The United States
• 3.2. Europe
• 3.3. Japan
• 3.4. China

4. Insulin Infusion Pumps Market Key Factors Analysis

• 4.1. Insulin Infusion Pumps Market Drivers
  • 4.1.1. Increasing prevalence of diabetes
  • 4.1.2. Rising awareness on diabetes
  • 4.1.3. Increasing focus on developing new products
• 4.2. Insulin Infusion Pumps Market Restraints and Challenges
  • 4.2.1. Availability of alternative products
  • 4.2.2. High cost of insulin infusion pumps
• 4.3. Insulin Infusion Pumps Market Opportunities
  • 4.3.1. Technological advancements such as improving product safety

5. Insulin Infusion Pumps Market Porter's Five Forces Analysis

• 5.1. Bargaining Power of Suppliers
• 5.2. Bargaining Power of Consumers
• 5.3. Threat of New Entrants
• 5.4. Threat of Substitutes
• 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Insulin Infusion Pumps Market

7. Insulin infusion pump Market Layout

• 7.1. By Product Type
  • 7.1.1. Patch pump
  • 7.1.2. Tethered pump
  • 7.1.3. Others
• 7.2. By Component
  • 7.2.1. Insulin Pump
  • 7.2.2. Infusion Set
  • 7.2.3. Reservoir
• 7.3. By Distribution Channels
  • 7.3.1. Hospital and Retail Pharmacy
  • 7.3.2. E-commerce sites
  • 7.3.3. Others
• 7.4. By Geography
  • 7.4.1. North America
    • 7.4.1.1. United States Insulin Infusion Pumps Market in USD million (2021-2030)
    • 7.4.1.2. Canada Insulin Infusion Pumps Market in USD million (2021-2030)
    • 7.4.1.3. Mexico Insulin Infusion Pumps Market in USD million (2021-2030)
  • 7.4.2. Europe
    • 7.4.2.1. France Insulin Infusion Pumps Market in USD million (2021-2030)
    • 7.4.2.2. Germany Insulin Infusion Pumps Market in USD million (2021-2030)
    • 7.4.2.3. United Kingdom Insulin Infusion Pumps Market in USD million (2021-2030)
    • 7.4.2.4. Italy Insulin Infusion Pumps Market in USD million (2021-2030)
    • 7.4.2.5. Spain Insulin Infusion Pumps Market in USD million (2021-2030)
    • 7.4.2.6. Russia Insulin Infusion Pumps Market in USD million (2021-2030)
    • 7.4.2.7. Rest of Europe Insulin Infusion Pumps Market in USD million (2021-2030)
  • 7.4.3. Asia-Pacific
    • 7.4.3.1. China Insulin Infusion Pumps Market in USD million (2021-2030)
    • 7.4.3.2. Japan Insulin Infusion Pumps Market in USD million (2021-2030)
    • 7.4.3.3. India Insulin Infusion Pumps Market in USD million (2021-2030)
    • 7.4.3.4. Australia Insulin Infusion Pumps Market in USD million (2021-2030)
    • 7.4.3.5. South Korea Insulin Infusion Pumps Market in USD million (2021-2030)
    • 7.4.3.6. Rest of Asia Pacific Insulin Infusion Pumps Market in USD million (2021-2030)
  • 7.4.4. Rest of the World (RoW)
    • 7.4.4.1. Middle East Insulin Infusion Pumps Market in USD million (2021-2030)
    • 7.4.4.2. Africa Insulin Infusion Pumps Market in USD million (2021-2030)
    • 7.4.4.3. South America Insulin Infusion Pumps Market in USD million (2021-2030)

8. Insulin Infusion Pumps Market Global Company Share Analysis - Key 3-5 Companies

9. Insulin Infusion Pumps Market Company and Product Profiles

• 9.1. F. Hoffmann-La Roche Ltd
  • 9.1.1. Company Overview
  • 9.1.2. Company Snapshot
  • 9.1.3. Financial Overview
  • 9.1.4. Product Listing
  • 9.1.5. Entropy
• 9.2. Medtrum Technologies Inc
  • 9.2.1. Company Overview
  • 9.2.2. Company Snapshot
  • 9.2.3. Financial Overview
  • 9.2.4. Product Listing
  • 9.2.5. Entropy
• 9.3. A. Menarini Diagnostics S.R.L
  • 9.3.1. Company Overview
  • 9.3.2. Company Snapshot
  • 9.3.3. Financial Overview
  • 9.3.4. Product Listing
  • 9.3.5. Entropy
• 9.4. IA Collaborative Holdings, LLC
  • 9.4.1. Company Overview
  • 9.4.2. Company Snapshot
  • 9.4.3. Financial Overview
  • 9.4.4. Product Listing
  • 9.4.5. Entropy
• 9.5. Apex Medical
  • 9.5.1. Company Overview
  • 9.5.2. Company Snapshot
  • 9.5.3. Financial Overview
  • 9.5.4. Product Listing
  • 9.5.5. Entropy
• 9.6. Medtronic
  • 9.6.1. Company Overview
  • 9.6.2. Company Snapshot
  • 9.6.3. Financial Overview
  • 9.6.4. Product Listing
  • 9.6.5. Entropy
• 9.7. Insulet Corporation
  • 9.7.1. Company Overview
  • 9.7.2. Company Snapshot
  • 9.7.3. Financial Overview
  • 9.7.4. Product Listing
  • 9.7.5. Entropy
• 9.8. Ascensia Diabetes Care Holdings AG
  • 9.8.1. Company Overview
  • 9.8.2. Company Snapshot
  • 9.8.3. Financial Overview
  • 9.8.4. Product Listing
  • 9.8.5. Entropy
• 9.9. Ypsomed AG
  • 9.9.1. Company Overview
  • 9.9.2. Company Snapshot
  • 9.9.3. Financial Overview
  • 9.9.4. Product Listing
  • 9.9.5. Entropy
• 9.10. Tandem Diabetes Care, Inc.
  • 9.10.1. Company Overview
  • 9.10.2. Company Snapshot
  • 9.10.3. Financial Overview
  • 9.10.4. Product Listing
  • 9.10.5. Entropy
• 9.11. ICU Medical, Inc.
  • 9.11.1. Company Overview
  • 9.11.2. Company Snapshot
  • 9.11.3. Financial Overview
  • 9.11.4. Product Listing
  • 9.11.5. Entropy
• 9.12. SOOIL Developments Co., Ltd.
  • 9.12.1. Company Overview
  • 9.12.2. Company Snapshot
  • 9.12.3. Financial Overview
  • 9.12.4. Product Listing
  • 9.12.5. Entropy
• 9.13. MicroPort Scientific Corporation
  • 9.13.1. Company Overview
  • 9.13.2. Company Snapshot
  • 9.13.3 Financial Overview
  • 9.13.4 Product Listing
  • 9.13.5. Entropy
• 9.14. Microtec Medical
  • 9.14.1. Company Overview
  • 9.14.2. Company Snapshot
  • 9.14.3. Financial Overview
  • 9.14.4. Product Listing
  • 9.14.5. Entropy

10. KOL Views

11. Project Approach

12. About DelveInsight

13. Disclaimer & Contact Us